Endocannabinoids as biomarkers of human reproduction

Human Reproduction Update

Volumn 20, Issue 4, 2014, Pages 501-516

  Rapino, Cinzia ^a,b   Battista, Natalia ^a,c   Bari, Monica ^c,d   Maccarrone, Mauro ^c,e  

^a UNIVERSITY OF TERAMO   (Italy)

^b Stem TeCh Group   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Biomarkers; Endocannabinoids; Human reproduction; Infertility; Pregnancy

Indexed keywords

ANANDAMIDE; ENDOCANNABINOID;

ANALYTICAL PARAMETERS; ARTICLE; CLINICAL PRACTICE; ENDOCANNABINOID BLOOD LEVEL; FEMALE FERTILITY; FEMALE GENITAL SYSTEM; HUMAN; MALE FERTILITY; MALE GENITAL SYSTEM; MALE GENITAL TRACT PARAMETERS; MOTHER FETUS RELATIONSHIP; OOCYTE MATURATION; OVARY FOLLICLE FLUID; OVARY FOLLICLE MATURATION; PREGNANCY; PRIORITY JOURNAL; REPRODUCTION; SPERM FUNCTION;

BIOMARKERS; ENDOCANNABINOIDS; HUMAN REPRODUCTION; INFERTILITY; PREGNANCY;

ANIMALS; ARACHIDONIC ACIDS; BIOLOGICAL MARKERS; ENDOCANNABINOIDS; EXTRAEMBRYONIC MEMBRANES; FEMALE; GENITALIA, FEMALE; GENITALIA, MALE; HUMANS; INFERTILITY; MALE; OOCYTES; PLACENTA; POLYUNSATURATED ALKAMIDES; PREGNANCY; PREGNANCY OUTCOME; REPRODUCTION; SPERMATOZOA;

EID: 84902985771     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmu004     Document Type: Article

References (199)

1. Abán C, Leguizamón GF, Cella M, Damiano A, Franchi AM, Farina MG. Differential expression of endocannabinoid system in normal and preeclamptic placentas: effects on nitric oxide synthesis. Placenta 2013;34:67-74.
2. Abdelazim IA. Fetal fibronectin (Quick Check fFN test(w)) for detection of premature rupture of fetal membranes. Arch Gynecol Obstet 2013;287:205-210.
3. Achache H, Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update 2006;12:731-746.
4. Acone G, Trabucco E, Colacurci N, Cobellis L, Mackie K, Meccariello R, Cacciola G, Chioccarelli T, Fasano S, Pierantoni R et al. Low type I cannabinoid receptor levels characterize placental villous in labouring delivery. Placenta 2009;30:203-205.
5. Agarwal A, Said TM. Role of sperm chromatin abnormalities and DNA damage in male infertility. Hum Reprod Update 2003;9:331-345.
6. Aghajanova L. Leukemia inhibitory factor and human embryo implantation. Ann N Y Acad Sci 2004;1034:176-183.
7. Agirregoitia E, Carracedo A, Subirán N, Valdivia A, Agirregoitia N, Peralta L, Velasco G, Irazusta J. The CB(2) cannabinoid receptor regulates human sperm cell motility. Fertil Steril 2010;93:1378-1387.
8. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 1:327-332.
9. Ahmadi A, Ng SC. Fertilizing ability of DNA-damaged spermatozoa. J Exp Zool 1999; 284:696-704.
10. Ahrens K, Mumford SL, Schliep KC, Kissell KA, Neil MD, Perkins J, Wactawski-Wende J, Schisterman EF. Serum leptin levels and reproductive function during the menstrual cycle. Am J Obstet Gynecol 2013; in press. doi: 10.1016/j.ajog.2013.11.009.
11. Aitken RJ. Human spermatozoa: revelations on the road to conception. F1000Prime Rep 2013;5:39.
12. Ajala OM, Ogunro PS, Elusanmi GF, Ogunyemi OE, Bolarinde AA. Changes in serum leptin during phases of menstrual cycle of fertile women: relationship to age groups and fertility. Int J Endocrinol Metab 2013;11:27-33.
13. Altman DG, McShane LM, Sauerbrei W, Taube SE. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration. PLoS Med 2012;9:e1001216.
14. Ambrosini A, Zolese G, Wozniak M, Genga D, Boscaro M, Mantero F, Balercia G. Idiopathic infertility: susceptibility of spermatozoa to in-vitro capacitation, in the presence and the absence of palmitylethanolamide (a homologue of anandamide), is strongly correlated with membrane polarity studied by Laurdan fluorescence. Mol Hum Reprod 2003;9:381-388.
15. Ambrosini A, Zolese G, Ambrosi S, Bertoli E, Mantero F, Boscaro M, Balercia G. Idiopathic infertility: effect of palmitoylethanolamide (a homologue of anandamide) on hyperactivated sperm cell motility and Ca2+ influx. J Androl 2005;26:429-436.
16. Amoako AA, Marczylo TH, Lam PM, Willets JM, Derry A, Elson J, Konje JC. Quantitative analysis of anandamide and related acylethanolamides in human seminal plasma by ultra performance liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:3231-3237.
17. Amoako AA, Marczylo TH, Marczylo EL, Elson J, Willets JM, Taylor AH, Konje JC. Anandamide modulates human sperm motility: implications for men with asthenozoospermia and oligoasthenoteratozoospermia. Hum Reprod 2013; 28:2058-2066.
18. Aquila S, Guido C, Laezza C, Santoro A, Pezzi V, Panza S, Andò S, Bifulco M. Anew role of anandamide in human sperm: focus on metabolism. J Cell Physiol 2009; 221:147-153.
19. Aquila S, Guido C, Santoro A, Gazzerro P, Laezza C, Baffa MF, Andò S, Bifulco M. Rimonabant (SR141716) induces metabolism and acquisition of fertilizing ability in human sperm. Br J Pharmacol 2010a;159:831-841.
20. Aquila S, Guido C, Santoro A, Perrotta I, Laezza C, Bifulco M, Sebastiano A. Human sperm anatomy: ultrastructural localization of the cannabinoid1 receptor and a potential role of anandamide in sperm survival and acrosome reaction. Anat Rec 2010b;293:298-309.
21. Arck P, Hansen PJ, Mulac Jericevic B, Piccinni MP, Szekeres-Bartho J. Progesterone during pregnancy: endocrine-immune cross talk in mammalian species and the role of stress. Am J Reprod Immunol 2007;58:268-279.
22. Ayalon D, Nir I, Cordova T, Bauminger S, Puder M, Naor Z, Kashi R, Zor U, Harell A, Lindner HR. Acute effect of delta1-tetrahydrocannabinol on the hypothalamo-pituitary-ovarian axis in the rat. Neuroendocrinology 1977;23:31-42.
23. Badawy ZS, Chohan KR, Whyte DA, Penefsky HS, Brown OM, Souid AK. Cannabinoids inhibit the respiration of human sperm'. Fertil Steril 2009; 91:2471-2476.
24. Bagavandoss P, Grimshaw S. Temporal and spatial distribution of the cannabinoid receptors (CB1, CB2) and fatty acid amide hydroxylase in the rat ovary. Anat Rec (Hoboken) 2010;293:1425-1432.
25. Bambang KN, Lambert DG, Lam PMW, Quenby S, Maccarrone M, Konje JC. Immunity and early pregnancy events: are endocannabinoids the missing link? J Reprod Immunol 2012;96:8-18.
26. Barash A, Dekel N, Fieldust S, Segal I, Schechtman E, Granot I. Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization. Fertil Steril 2003;79:1317-1322.
27. Barbonetti A, Vassallo MR, Fortunato D, Francavilla S, Maccarrone M, Francavilla F. Energetic metabolism and human sperm motility: impact of CB1 receptor activation. Endocrinology 2010;151:5882-5892.
28. Bari M, Battista N, Pirazzi V, Maccarrone M. The manifold actions of endocannabinoids on female and male reproductive events. Front Biosci 2011;16:498-516.
29. Barnhart KT, Sammel MD, Appleby D, Rausch M, Molinaro T, Van Calster B, Kirk E, Condous G, Van Huffel S, Timmerman D et al. Does a prediction model for pregnancy of unknown location developed in the UK validate on a US population? Hum Reprod 2010;25:2434-2440.
30. Battista N, Meccariello R, Cobellis G, Fasano S, Di Tommaso M, Pirazzi V, Konje JC, Pierantoni R, Maccarrone M. The role of endocannabinoids in gonadal function and fertility along the evolutionary axis. Mol Cell Endocrinol 2012;355:1-14.
31. Battista N, Sergi M, Montesano C, Napoletano S, Compagnone D, Maccarrone M. Analytical approaches for the determination of phytocannabinoids and endocannabinoids in human matrices. Drug Test Anal 2014;6:7-16.
32. Belo L, Santos-Silva A, Rumley A, Lowe G, Pereira-Leite L, Quintanilha A, Rebelo I. Elevated tissue plasminogen activator as a potential marker of endothelial dysfunction in pre-eclampsia: correlation with proteinuria. BJOG 2002; 109:1250-1255.
33. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 2003;163:463-468.
34. Brocato B, Zoerner AA, Janjetovic Z, Skobowiat C, Gupta S, Moore BM, Slominski A, Zhang J, Schenone M, Phinehas R et al. Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp. ) of obesity. Placenta 2013; 34:983-989.
35. Buczynski MW, Parsons LH. Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls. Br J Pharmacol 2010;160:423-442.
36. Buffone MG, Ijiri TW, Cao W, Merdiushev T, Aghajanian HK, Gerton GL. Heads or tails? Structural events and molecular mechanisms that promote mammalian sperm acrosomal exocytosis and motility. Mol Reprod Dev 2012;79:4-18.
37. Cacciola G, Chioccarelli T, Ricci G, Meccariello R, Fasano S, Pierantoni R, Cobellis G. The endocannabinoid system in vertebrate male reproduction: a comparative overview. Mol Cell Endocrinol 2008;286:S24-S30.
38. Cencioni MT, Chiurchiù V, Catanzaro G, Borsellino G, Bernardi G, Battistini L, Maccarrone M. Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. PLoS One 2010;5:e8688.
39. Cha J, Sun X, Dey SK. Mechanisms of implantation: strategies for successful pregnancy. Nat Med 2012;18:1754-1767.
40. Chan HW, McKirdy NC, Peiris HN, Rice GE, Mitchell MD. The role of endocannabinoids in pregnancy. Reproduction 2013;146:101-109.
41. Chicca A, Marazzi J, Nicolussi S, Gertsch J. Evidence for bidirectional endocannabinoid transport across cell membranes. J Biol Chem 2012;287:34660-34682.
42. Chioccarelli T, Cacciola G, Altucci L, Lewis SE, Simon L, Ricci G, Ledent C, Meccariello R, Fasano S, Pierantoni R et al. Cannabinoid receptor 1 influences chromatin remodeling in mouse spermatids by affecting content of transition protein 2 mRNA and histone displacement. Endocrinology 2010;151:5017-5029.
43. Cobellis G, Cacciola G, Scarpa D, Meccariello R, Chianese R, Franzoni MF, Mackie K, Pierantoni R, Fasano S. Endocannabinoid system in frog and rodent testis: type-1 cannabinoid receptor and fatty acid amide hydrolase activity in male germ cells. Biol Reprod 2006;75:82-89.
44. Cobellis G, Ricci G, Cacciola G, Orlando P, Petrosino S, Cascio MG, Bisogno T, De Petrocellis L, Chioccarelli T, Altucci L et al. A gradient of 2-arachidonoylglycerol regulates mouse epididymal sperm cell start-up. Biol Reprod 2010;82:451-458.
45. Cole LA, Kardana A, Seifer DB, Bohler HCL. Urine hCG b-subunit core fragment, a sensitive test for ectopic pregnancy. J Clin Endocrinol Metab 1994;78:497-499.
46. Cowan BD, Vandermolen DT, Long CA, Whitworth NS. Receiver operator characteristic, efficiency analysis, and predictive value of serum progesterone concentration as a test for abnormal gestations. Am J Obstet Gynecol 1992;166:1729-1737.
47. Daponte A, Deligeoroglou E, Garas A, Pournaras S, Hadjichristodoulou C, Messinis IE. Activin a and follistatin as biomarkers for ectopic pregnancy and missed abortion. Dis Markers 2013;35:497-503.
48. Das M, Holzer HE. Recurrent implantation failure: gamete and embryo factors. Fertil Steril 2012;97:1021-1027.
49. Derocq JM, Jbilo O, Bouaboula M, Ségui M, Clère C, Casellas P. Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation. J Biol Chem 2000;275:15621-15628.
50. Di Blasio AM, Vignali M, Gentilini D. The endocannabinoid pathway and the female reproductive organs. J Mol Endocrinol 2013;50:1-9.
51. Diesch CH, Holzgreve W, Hahn S, Zhong XY. Comparison of activin A and cell-free fetal DNA levels in maternal plasma from patients at high risk for preeclampsia. Prenat Diagn 2006;26:1267-1270.
52. Di Marzo V, De Petrocellis L. Endocannabinoids as regulators of transient receptor potential (TRP) channels: a further opportunity to develop new endocannabinoidbased therapeutic drugs. Curr Med Chem 2010;17:1430-1449.
53. Di Marzo V, Petrosino S. Endocannabinoids and the regulation of their levels in health and disease. Curr Opin Lipidol 2007;18:129-140.
54. Di Marzo V, Sepe N, De Petrocellis L, Berger A, Crozier G, Fride E, Mechoulam R. Trick or treat from food endocannabinoids? Nature 1998;396:636-637.
55. Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 2002;99:10819-10824.
56. Domingues TS, Rocha AM, Serafini PC. Tests for ovarian reserve: reliability and utility. Curr Opin Obstet Gynecol 2010;22:271-276.
57. El-Talatini MR, Taylor AH, Konje JC. Fluctuation in anandamide levels from ovulation to early pregnancy in in-vitro fertilization-embryo transfer women, and its hormonal regulation. Hum Reprod 2009a;24:1989-1998.
58. El-Talatini MR, Taylor AH, Elson JC, Brown L, Davidson AC, Konje JC. Localisation and function of the endocannabinoid system in the human ovary. PLoS One 2009b; 4:e4579.
59. El-Talatini MR, Taylor AH, Konje JC. The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle. Fertil Steril 2010;93:1989-1996.
60. Fanelli F, Di Lallo VD, Belluomo I, De Iasio R, Baccini M, Casadio E, Gasparini DI, Colavita M, Gambineri A, Grossi G et al. Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC/MS/MS. J Lipid Res 2012;53:481-493.
61. Fassbender A, Vodolazkaia A, Saunders P, Lebovic D, Waelkens E, De Moor B, D'Hooghe T. Biomarkers of endometriosis. Fertil Steril 2013;15:1135-1145.
62. Fawcett T. An introduction to ROC analysis. Pattern Recognit Lett 2006;27:861-874.
63. Fedorcsák P, Storeng R, Dale PO, Tanbo T, Abyholm T. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand 2000;79:43-48.
64. Fedorcsák P, Dale PO, Storeng R, Ertzeid G, Bjercke S, Oldereid N, Omland AK, Abyholm T, Tanbo T. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 2004;19:2523-2528.
65. Fezza F, De Simone C, Amadio D, Maccarrone M. Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system. Subcell Biochem 2008;49:101-132.
66. Fonseca M, Correia-da-Silva G, Taylor AH, Lam PM, Marczylo TH, Bell SC, Konje JC, Teixeira NA. The endocannabinoid 2-arachidonoylglycerol (2-AG) and metabolizing enzymes during rat fetoplacental development: a role in uterine remodelling. Int J Biochem Cell Biol 2010;42:1884-1892.
67. Fowler CJ. Transport of endocannabinoids across the plasma membrane and within the cell. FEBS J 2013;280:1895-1904.
68. Francavilla F, Battista N, Barbonetti A, Vassallo MR, Rapino C, Antonangelo C, Pasquariello N, Catanzaro G, Barboni B, Maccarrone M. Characterization of the endocannabinoid system in human spermatozoa and involvement of transient receptor potential vanilloid 1 receptor in their fertilizing ability. Endocrinology 2009;150:4692-4700.
69. Fu J, Bottegoni G, Sasso O, Bertorelli R, Rocchia W, Masetti M, Guijarro A, Lodola A, Armirotti A, Garau G et al. A catalytically silent FAAH-1 variant drives anandamide transport in neurons. Nat Neurosci 2011;15:64-69.
70. García Mdel C, Adler-Graschinsky E, Celuch SM. Enhancement of the hypotensive effects of intrathecally injected endocannabinoids by the entourage compound palmitoylethanolamide. Eur J Pharmacol 2009;610:75-80.
71. Gasperi V, Dainese E, Oddi S, Sabatucci A, Maccarrone M. GPR55 and its interaction with membrane lipids: comparison with other endocannabinoid-binding receptors. Curr Med Chem 2013;20:64-78.
72. Gebeh K, Willets JM, Marczylo EL, Taylor AH, Konje JC. Ectopic pregnancy is associated with high anandamide levels and aberrant expression of FAAH and CB1 in fallopian tubes. J Clin Endocrinol Metab 2012;97:2827-2835.
73. Gebeh K, Willets JM, Bari M, Hirst RA, Marczylo TH, Taylor AH, Maccarrone M, Konje JC. Elevated anandamide and related N-acylethanolamine levels occur in the peripheral blood of women with ectopic pregnancy and are mirrored by changes in peripheral fatty acid amide hydrolase activity. JCEM 2013a; 98:1226-1234.
74. Gebeh AK, Willets JM, Marczylo TH, Konje JC. Plasma anandamide and related n-acylethanolamide levels are not elevated in pregnancies complicated by hyperemesis gravidarum. J Matern Fetal Neonatal Med 2013b (in press).
75. Grosskinsky CM, Hage ML, Tyrey L, Christakos AC, Hughes CL. hCG, progesterone, alphafetoprotein, and estradiol in the identification of ectopic pregnancy. Obstet Gynecol 1993;81:705-709.
76. Guida M, Ligresti A, De Filippis D, D'Amico A, Petrosino S, Cipriano M, Bifulco G, Simonetti S, Orlando P, Insabato L et al. The levels of the endocannabinoid receptor CB2 and its ligand 2-arachidonoylglycerol are elevated in endometrial carcinoma. Endocrinology 2010;151:921-928.
77. Guo Y, Wang H, Okamoto Y, Ueda N, Kingsley PJ, Marnett LJ, Schmid HH, Das SK, Dey SK. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. J Biol Chem 2005;280:23429-23432.
78. Guzick DS, Sullivan MW, Adamson GD, Cedars MI, Falk RJ, Peterson EP, Steinkampf MP. Efficacy of treatment for unexplained infertility. Fertil Steril 1998; 70:207-213.
79. Guzick DS, Overstreet JW, Factor-Litvak P, Brazil CK, Nakajima ST, Coutifaris C, Carson SA, Cisneros P, Steinkampf MP, Hill JA et al. Sperm morphology, motility, and concentration in infertile and fertile men. N Engl J Med 2001;345:1388-1393.
80. Habayeb OM, Taylor AH, Evans DM, Cooke MS, Taylor DJ, Bell SC, Konje JC. Plasma levels of the endocannabinoid anandamide in women a potential role in pregnancy maintenance and labor? JCEM 2004;89:5482-5487.
81. Habayeb OM, Taylor AH, Finney M, Evans MD, Konje JC. Plasma anandamide concentration and pregnancy outcome in women with threatened miscarriage. JAMA 2008a;299:1135-1136.
82. Habayeb OM, Taylor AH, Bell SC, Taylor DJ, Konje JC. Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation. Endocrinology 2008b;149:5052-5060.
83. Hardarson T, Ahlström A, Rogberg L, Botros L, Hillensjö T, Westlander G, Sakkas D, Wikland M. Non-invasive metabolomic profiling of Day 2 and 5 embryo culture medium: a prospective randomized trial. Hum Reprod 2012;27:89-96.
84. Hardie L, Trayhurn P, Abramovich D, Fowler P. Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy. Clin Endocrinol (Oxf) 1997;47:101-106.
85. Helliwell RJ, Chamley LW, Blake-Palmer K, Mitchell MD, Wu J, Kearn CS, Glass M. Characterization of the endocannabinoid system in early human pregnancy. J Clin Endocrinol Metab 2004;89:5168-5174.
86. Henson MC, Castracane VD. Leptin in pregnancy: an update. Biol Reprod 2006; 74:218-229.
87. Iliodromiti S, Kelsey TW, Anderson RA, Nelson SM. Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. J Clin Endocrinol Metab 2013;98:3332-3340.
88. Iuvone T, De Filippis D, Di Spiezio Sardo A, D'Amico A, Simonetti S, Sparice S, Esposito G, Bifulco G, Insabato L, Nappi C et al. Selective CB2 up-regulation in women affected by endometrial inflammation. J Cell Mol Med 2008;12:661-670.
89. Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 2009;30:515-527.
90. Jequier AM. Semen analysis: a new manual and its application to the understanding of semen and its pathology. Asian J Androl 2010;12:11-13.
91. Jonsson KO, Vandevoorde S, Lambert DM, Tiger G, Fowler CJ. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. Br J Pharmacol 2001;133:1263-1275.
92. Kagan KO, Hoopmann M, Abele H, Alkier R, Lüthgens K. First-trimester combined screening for trisomy 21 with different combinations of placental growth factor, free b-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2012;40:530-535.
93. Karasu T, Marczylo TH, Maccarrone M, Konje JC. The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility. Hum Reprod Update 2011;17:347-361.
94. Kishimoto S, Kobayashi Y, Oka S, Gokoh M, Waku K, Sugiura T. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells. J Biochem 2004;135:517-524.
95. Klein TW, Newton C, Larsen K, Chou J, Perkins I, Lu L, Nong L, Friedman H. Cannabinoid receptors and T helper cells. J Neuroimmunol 2004;147:91-94.
96. Kozak KR, Crews BC, Ray JL, Tai HH, Morrow JD, Marnett LJ. Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo. J Biol Chem 2001;276:36993-36998.
97. Kozak KR, Crews BC, Morrow JD, Wang LH, Ma HY, Weinander R, Jakobsson PJ, Marnett LJ. Metabolism of the endocannabinoids, 2-arachidonoyglkycerol and anandamide, into prostaglandin, tromboxane, and prostacyclin glycerol esters and ethanolamides. J Biol Chem 2002;277:44877-44885.
98. Krause TG, Christens P, Wohlfahrt J, Lei U, Westergaard T, Nørgaard-Pedersen B, Melbye M. Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome(1). Obstet Gynecol 2001;97:277-282.
99. Kuc S, Wortelboer EJ, van Rijn BB, Franx A, Visser GH, Schielen PC. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv 2011;66:225-239.
100. Kumar PG, Shoeb M. The role of trp ion channels in testicular function. Adv Exp Med Biol 2011;704:881-908.
101. Laird SM, Tuckerman EM, Dalton CF, Dunphy BC, Li TC, Zhang X. The production of leukaemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture. Hum Reprod 1997;12:569-574.
102. Lam PM, Marczylo TH, El-Talatini M, Finney M, Nallendran V, Taylor AH, Konje JC. Ultra performance liquid chromatography tandem mass spectrometry method for the measurement of anandamide in human plasma. Anal Biochem 2008; 380:195-201.
103. Lam PM, Marczylo TH, Konje JC. Simultaneous measurement of three N-acylethanolamides in human bio-matrices using ultra performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2010; 398:2089-2097.
104. Lambert-Messerlian GM, Canick JA. Clinical application of inhibin a measurement: prenatal serum screening for Down syndrome. Semin Reprod Med 2004; 22:235-242.
105. Lazzarin N, Valensise H, Bari M, Ubaldi F, Battista N, Finazzi-Agrò A, Maccarrone M. Fluctuations of fatty acid amide hydrolase and anandamide levels during the human ovulatory cycle. Gynecol Endocrinol 2004;18:212-218.
106. Lédée N, Petitbarat M, Rahmati M, Dubanchet S, Chaouat G, Sandra O, Perrier-d'Hauterive S, Munaut C, Foidart JM. New pre-conception immune biomarkers for clinical practice: interleukin-18, interleukin-15 and TWEAK on the endometrial side, G-CSF on the follicular side. J Reprod Immunol 2011; 88:118-123.
107. Lee JY, Lee M, Lee SK. Role of endometrial immune cells in implantation. Clin Exp Reprod Med 2011;38:119-125.
108. Leung K, Elmes MW, Glaser ST, Deutsch DG, Kaczocha M. Role of FAAH-like anandamide transporter in anandamide inactivation. PLoS One 2013;8:e79355.
109. Lewis SE, Maccarrone M. Endocannabinoids, sperm biology and human fertility. Pharmacol Res 2009;60:126-131.
110. Lewis LS, Rapino C, Di Tommaso M, Pucci M, Battista N, Paro R, Simon L, Lutton D, Maccarrone M. Differences in the endocannabinoid system of sperm from fertile and infertile men. PLoS One 2012;7:e47704.
111. Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, Dey SK. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 1997; 91:197-208.
112. Linne Y. Effects of obesity on women's reproduction and complications during pregnancy. Obes Rev 2004;5:137-143.
113. Liu WM, Duan EK, Cao YJ. Effects of anandamide on embryoimplantation in themouse. Life Sci 2002;71:1623-1632.
114. Maccarrone M. Endocannabinoids: friends and foes of reproduction. Prog Lipid Res 2009;48:344-354.
115. Maccarrone M. Endocannabinoids as markers of sperm quality: hot spots. Front Endocrinol (Lausanne) 2013;4:169.
116. Maccarrone M, Finazzi-Agrò A. Anandamide hydrolase: a guardian angel of human reproduction? Trends Pharmacol Sci 2004;25:353-357.
117. Maccarrone M, Wenger T. Effects of cannabinoids on hypothalamic and reproductive function. Hand Exp Pharmacol 2005;168:555-571.
118. Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agrò A. Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet 2000;355:1329-1329.
119. Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agrò A. Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility. J Immunol 2001;166:7183-7189.
120. Maccarrone M, Bisogno T, Valensise H, Lazzarin N, Fezza F, Manna C, Di Marzo V, Finazzi-Agrò A. Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol Hum Reprod 2002a;8:188-195.
121. Maccarrone M, Bari M, Battista N, Finazzi-Agrò A. Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation. Blood 2002b;100:4040-4048.
122. Maccarrone M, Bari M, Di Rienzo M, Finazzi-Agrò A, Rossi A. Progesterone activates fatty acid amide hydrolase (FAAH) promoter in human T lymphocytes through the transcription factor Ikaros. Evidence for a synergistic effect of leptin. J Biol Chem 2003a;278:32726-32732.
123. Maccarrone M, Cecconi S, Rossi G, Battista N, Pauselli R, Finazzi-Agrò A. Anandamide activity and degradation are regulated by early postnatal aging and follicle-stimulating hormone in mouse Sertoli cells. Endocrinology 2003b;144:20-28.
124. Maccarrone M, Barboni B, Paradisi A, Bernabò N, Gasperi V, Pistilli MG, Fezza F, Lucidi P, Mattioli M. Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction. J Cell Sci 2005;118:4393-4404.
125. Maccarrone M, Dainese E, Oddi S. Intracellular trafficking of anandamide: newconcepts for signaling. Trends Biochem Sci 2010;35:601-608.
126. Marczylo TH, Lam PM, Nallendran V, Taylor AH, Konje JC. A solid-phase method for the extraction and measurement of anandamide from multiple human biomatrices. Anal Biochem 2009;384:106-113.
127. Marczylo TH, Lam PM, Amoako AA, Konje JC. Anandamide levels in human female reproductive tissues: solid-phase extraction and measurement by ultraperformance liquid chromatography tandem mass spectrometry. Anal Biochem 2010;400:155-162.
128. McKinney MK, Cravatt BF. Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 2005;74:411-432.
129. Mechoulam R, Parker LA. The endocannabinoid system and the brain. Annu Rev Psychol 2013;64:21-47.
130. Metwally M, Ledger WL. Reproductive endocrinology and clinical aspects of obesity in women. Ann N Y Acad Sci 2008;1127:140-146.
131. Mihu D, Costin N, Mihu CM, Blaga LD, Pop RB. C-reactive protein, marker for evaluation of systemic inflammatory response in preeclampsia. Rev Med Chir Soc Med Nat Iasi 2008;112:1019-1025.
132. Mitchell MD, Sato TA, Wang A, Keelan JA, Ponnampalam AP, Glass M. Cannabinoids stimulate prostaglandin production by human gestational tissues through a tissueand CB1-receptor-specific mechanism. Am J Physiol Endocrinol Metab 2008; 294:E352-E356.
133. Nallendran V, Lam PM, Marczylo TH, Bankart MJ, Taylor AH, Taylor DJ, Konje JC. The plasma levels of the endocannabinoid, anandamide, increase with the induction of labour. BJOG 2010;117:863-869.
134. Ness RB, McLaughlin MT, Heine RP, Bass DC, Mortimer L. Fetal fibronectin as a biomarker to discriminate between ectopic and intrauterine pregnancies. Am J Obstet Gynecol 1998;179:697-702.
135. Nicolaides KH, Wright D, Poon LC, Syngelaki A, Gil MM. First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing. Ultrasound Obstet Gynecol 2013;42:41-50.
136. Nir I, Ayalon D, Tsafriri A, Cordova T, Lindner HR. Suppression of the cyclic surge of luteinizing hormone secretion and of ovulation in the rat by delta 1-tetrahydrocannabinol. Nature 1973;243:470-471.
137. Nolen BM, Lokshin AE. Biomarker testing for ovarian cancer: clinical utility of multiplex assays. Mol Diagn Ther 2013;17:139-146.
138. Okamoto Y, Tsuboi K, Ueda N. Enzymatic formation of anandamide. Vitam Horm 2009; 81:1-24.
139. Pacher P, Kunos G. Modulating the endocannabinoid system in human health and disease-successes and failures. FEBS J 2013;280:1918-1943.
140. Palkovits M, Harvey-White J, Liu J, Kovacs ZS, Bobest M, Lovas G, Bagó AG, Kunos G. Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain. Neuroscience 2008;152:1032-1039.
141. Palmer SS, Barnhart KT. Biomarkers in reproductive medicine: the promise, and can it be fulfilled? Fertil Steril 2013;99:954-962.
142. Paria BC, Ma W, Andrenyak DM, Schmid PC, Schmid HH, Moody DE, Deng H, Makriyannis A, Dey SK. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. Biol Reprod 1998;58:1490-1495.
143. Park B, Gibbons HM, Mitchell MD, Glass M. Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta. Placenta 2003;24:990-995.
144. Pepe MS, Feng Z, Huang Y, Longton G, Prentice R, Thompson IM, Zheng Y. Integrating the predictiveness of a marker with its performance as a classifier. Am J Epidemiol 2008;167:362-368.
145. Peralta L, Agirregoitia E, Mendoza R, Expósito A, Casis L, Matorras R, Agirregoitia N. Expression and localization of cannabinoid receptors in human immature oocytes and unfertilized metaphase-II oocytes. Reprod BioMed Online 2011;23:372-379.
146. Pertwee RG. Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications. Proc Nutr Soc 2013 (in press).
147. Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K et al. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev 2010;62:588-631.
148. Piccinni MP. T cell tolerance towards the fetal allograft. J Reprod Immunol 2010; 85:71-75.
149. Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 1998;4:1020-1024.
150. Pistis M, Melis M. From surface to nuclear receptors: the endocannabinoid family extends its assets. Curr Med Chem 2010;17:1450-1467.
151. Polsani S, Phipps E, Jim B. Emerging new biomarkers of preeclampsia. Adv Chronic Kidney Dis 2013;20:271-279.
152. Practice Committee of the American Society for Reproductive Medicine. The clinical utility of sperm DNA integrity testing: a guideline. Fertil Steril 2013;99:673-677.
153. Rausch ME, Barnhart KT. Serum biomarkers for detecting ectopic pregnancy. Clin Obstet Gynecol 2012;55:418-423.
154. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003;107:391-397.
155. Ross RA. The enigmatic pharmacology of GPR55. Trends Pharmacol Sci 2009; 30:156-163.
156. Rossato M. Endocannabinoids, sperm functions and energy metabolism. Mol Cell Endocrinol 2008;286:S31-S35.
157. Rossato M, Ion Popa F, Ferigo M, Clari G, Foresta C. Humansperm express cannabinoid receptor Cb1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function. J Clin Endocrinol Metab 2005;90:984-991.
158. Schuel H. Tuning the oviduct to the anandamide tone. J Clin Invest 2006; 116:2087-2090.
159. Schuel H, Goldstein E, Mechoulam R, Zimmerman AM, Zimmerman S. Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction. Proc Natl Acad Sci USA 1994;91:7678-7682.
160. Schuel H, Burkman LJ, Lippes J, Crickard K, Forester E, Piomelli D, Giuffrida A. N-Acylethanolamines in human reproductive fluids. Chem Phys Lipids 2002a; 121:211-227.
161. Schuel H, Burkman LJ, Lippes J, Crickard K, Mahony MC, Giuffrida A, Picone RP, Makriyannis A. Evidence that anandamide-signaling regulates human sperm functions required for fertilization. Mol Reprod Dev 2002b;63:376-387.
162. Seeber BE. What serial hCG can tell you, and cannot tell you, about an early pregnancy. Fertil Steril 2012;98:1074-1077.
163. Seifer DB, Lambert-Messerlian GM, Canick JA, Frishman GN, Schneyer AL. Serum inhibin levels are lower in ectopic than intrauterine spontaneously conceived pregnancies. Fertil Steril 1996;65:667-669.
164. Sen A, Kushnir VA, Barad DH, Gleicher N. Endocrine autoimmune diseases and female infertility. Nat Rev Endocrinol 2014;10:37-50.
165. Sharkey AM, King A, Clark DE, Burrows TD, Jokhi PP, Charnock-Jones DS, Loke YW, Smith SK. Localization of leukemia inhibitory factor and its receptor in human placenta throughout pregnancy. Biol Reprod 1999;60:355-364.
166. Shokry M, Bedaiwy MA, Fathalla MM, Alsemary A, Elwakil S, Murphy A. Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia. Acta Obstet Gynecol Scand 2010;89:143-146.
167. Smith SK, Charnock-Jones DS, Sharkey AM. The role of leukemia inhibitory factor and interleukin-6 in human reproduction. Hum Reprod 1998;13:237-243.
168. Stein RJ, Santos S, Nagatomi J, Hayashi Y, Minnery BS, Xavier M, Patel AS, Nelson JB, Futrell WJ, Yoshimura N et al. Cool (TRPM8) and hot (TRPV1) receptors in the bladder and male genital tract. J Urol 2004;172:1175-1178.
169. Stovall TG, Ling FW, Andersen RN, Buster JE. Improved sensitivity and specificity of a single measurement of serum progesterone over serial quantitative beta-human chorionic gonadotropin in screening for ectopic pregnancy. Hum Reprod 1992; 7:723-725.
170. Sucak A, Kanat-Pektas M, Gungor T, Mollamahmutoglu L. Leptin levels and antihypertensive treatment in preeclampsia. Singapore Med J 2010;51:39-43.
171. Sun X, Dey SK. Aspects of endocannabinoid signaling in periimplantation biology. Mol Cell Endocrinol 2008;286:S3-11.
172. Sun X, Dey SK. Endocannabinoid signaling in female reproduction. ACS Chem Neurosci 2012;3:349-355.
173. Sun X, Wang H, Okabe M, Mackie K, Kingsley PJ, Marnett LJ, Cravatt BF, Dey SK. Genetic loss of Faah compromises male fertility in mice. Biol Reprod 2009; 80:235-242.
174. Sun X, Xie H, Yang J, Wang H, Bradshaw HB, Dey SK. Endocannabinoid signaling directs differentiation of trophoblast cell lineages and placentation. Proc Natl Acad Sci USA 2010;107:16887-16892.
175. Taupin JL, Miossec V, Pitard V, Blanchard F, Daburon S, Raher S, Jacques Y, Godard A, Moreau JF. gp190, reveals a LIF binding site outside and interactions between the two cytokine binding domains. J Biol Chem 1999;274:14482-14489.
176. Taylor H, Ang C, Bell SC, Konje JC. The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy. Hum Reprod Update 2007; 13:501-513.
177. Taylor AH, Amoako AA, Bambang K, Karasu T, Gebeh A, Lam PM, Marzcylo TH, Konje JC. Endocannabinoids and pregnancy. Clin Chim Acta 2010;411: 921-930.
178. Taylor H, Finney M, Lam PM, Konje JC. Modulation of the endocannabinoid system in viable and non-viable first trimester pregnancies by pregnancy-related hormones. Reprod Biol Endocrinol 2011;29:152.
179. Tong S, Ngian GL, Onwude JL, Permezel M, Saglam B, Hay S, Konje JC, Marczylo TH, Fleming G, Walker SP et al. Diagnostic accuracy of maternal serum macrophage inhibitory cytokine-1 and pregnancy-associated plasma protein-A at 6-10 weeks of gestation to predict miscarriage. Obstet Gynecol 2012;119:1000-1008.
180. Toshimori K. Dynamics of the mammalian sperm head: modifications and maturation events from spermatogenesis to egg activation. Adv Anat Embryol Cell Biol 2009; 204:5-94.
181. Trabucco E, Acone G, Marenna A, Pierantoni R, Cacciola G, Chioccarelli T, Mackie K, Fasano S, Colacurci N, Meccariello R et al. Endocannabinoid system in first trimester placenta: low FAA Hand high CB1 expression characterize spontaneous miscarriage. Placenta 2009;30:516-522.
182. Ueda N, Tsuboi K, Uyama T, Ohnishi T. Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol. Biofactors 2011;37:1-7.
183. Ueda N, Tsuboi K, Uyama T. Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways. FEBS J 2013; 280:1874-1894.
184. Van der Stelt M, van Kuik JA, Bari M, van Zadelhoff G, Leeflang BR, Veldink GA, Finazzi Agro' A, Vliegenthart JF, Maccarrone M. Oxygenated metabolites of anandamide and 2-arachidonoyl-glycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter and fatty acid amide hydrolase. J Med Chem 2002;45:3709-3720.
185. Vasan SS. Semen analysis and sperm function tests:howmuch to test? Indian J Urol 2011; 27:41-48.
186. Vogeser M, Hauer D, Christina Azad S, Huber E, Storr M, Schelling G. Release of anandamide from blood cells. Clin Chem Lab Med 2006;44:488-491.
187. Volk M, Maver A, Lovrečić L, Juvan P, Peterlin B. Expression signature as a biomarker for prenatal diagnosis of trisomy 21. PLoS One 2013;8:e74184.
188. Voronina E, Wessel GM. The regulation of oocyte maturation. Curr Top Dev Biol 2003; 58:53-110.
189. Wang JX, Davies M, Norman RJ. Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. BMJ 2000;321: 1320-1321.
190. Wang JX, Davies MJ, Norman RJ. Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res 2002;10:551-554.
191. Wang H, Guo Y, Wang D, Kingsley PJ, Marnett LJ, Das SK, DuBois RN, Dey SK. Aberrant cannabinoid signaling impairs oviductal transport of embryos. Nat Med 2004;10:1074-1080.
192. Wang H, Dey SK, Maccarrone M. Jekyll and Hyde: two faces of cannabinoid signaling in male and female fertility. Endocr Rev 2006a;27:427-448.
193. Wang H, Xie H, Guo Y, Zhang H, Takahashi T, Kingsley PJ, Marnett LJ, Das SK, Cravatt BF, Dey SK. Fatty acid amide hydrolase deficiency limits early pregnancy events. J Clin Invest 2006b;116:2122-2131.
194. Wang H, Xie H, Dey SK. Loss of cannabinoid receptor CB1 induces preterm birth. PLoS One 2008;3:e3320.
195. Woodcock J. Assessing the clinical utility of diagnostics used in drug therapy. Clin Pharmacol Ther 2010;88:765-773.
196. Wu M, Yin Y, Zhao M, Hu L, Chen Q. The low expression of leukemia inhibitory factor in endometrium: possible relevant to unexplained infertility with multiple implantation failures. Cytokine 2013;62:334-339.
197. Xie H, Sun X, Piao Y, Jegga AG, Handwerger S, Ko MS, Dey SK. Silencing or amplification of endocannabinoid signaling in blastocysts via CB1 compromises trophoblast cell migration. J Biol Chem 2012;287:32288-32297.
198. Yu M, Ives D, Ramesha CS. Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. J Biol Chem 1997;272:21181-21186.
199. Zoerner AA, Gutzki FM, Batkai S, May M, Rakers C, Engeli S, Jordan J, Tsikas D. Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: a comprehensive review from an analytical and biological perspective. Biochim Biophys Acta 2011; 1811:706-723.